Stroke Department, Pierre Wertheimer Hospital, Hospices Civils de Lyon, 59 Boulevard Pinel, 69677, Bron, France.
INSERM U1060, CarMeN Laboratory, University Lyon 1, Lyon, France.
J Nucl Cardiol. 2022 Jun;29(3):1064-1074. doi: 10.1007/s12350-020-02400-0. Epub 2020 Nov 3.
Previous studies have suggested the role of microcalcifications in plaque vulnerability. This exploratory study sought to assess the potential of hybrid positron-emission tomography (PET)/magnetic resonance imaging (MRI) using F-sodium fluoride (F-NaF) to check simultaneously F-NaF uptake, a marker of microcalcifications, and morphological criteria of vulnerability.
We included 12 patients with either recently symptomatic or asymptomatic carotid stenosis. All patients underwent F-NaF PET/MRI. F-NaF target-to-background ratio (TBR) was measured in culprit and nonculprit (including contralateral plaques of symptomatic patients) plaques as well as in other arterial walls. Morphological criteria of vulnerability were assessed on MRI. Mineral metabolism markers were also collected. F-NaF uptake was higher in culprit compared to nonculprit plaques (median TBR 2.6 [2.2-2.8] vs 1.7 [1.3-2.2]; P = 0.03) but was not associated with morphological criteria of vulnerability on MRI. We found a positive correlation between F-NaF uptake and calcium plaque volume and ratio but not with circulating tissue-nonspecific alkaline phosphatase (TNAP) activity and inorganic pyrophosphate (PPi) levels. F-NaF uptake in the other arterial walls did not differ between symptomatic and asymptomatic patients.
F-NaF PET/MRI may be a promising tool for providing additional insights into the plaque vulnerability.
先前的研究表明微钙化在斑块易损性中的作用。本探索性研究旨在评估使用 F-氟酸钠(F-NaF)的正电子发射断层扫描(PET)/磁共振成像(MRI)混合技术的潜力,以同时检查 F-NaF 摄取,这是微钙化的标志物,以及易损性的形态学标准。
我们纳入了 12 名有近期症状性或无症状性颈动脉狭窄的患者。所有患者均接受了 F-NaF PET/MRI 检查。在罪犯斑块和非罪犯斑块(包括症状性患者的对侧斑块)以及其他动脉壁中测量 F-NaF 靶与背景比(TBR)。在 MRI 上评估易损性的形态学标准。还收集了矿物质代谢标志物。与非罪犯斑块相比,罪犯斑块的 F-NaF 摄取更高(中位数 TBR 2.6 [2.2-2.8] 比 1.7 [1.3-2.2];P=0.03),但与 MRI 上的易损性形态学标准无关。我们发现 F-NaF 摄取与钙斑块体积和比例呈正相关,但与循环组织非特异性碱性磷酸酶(TNAP)活性和无机焦磷酸盐(PPi)水平无关。症状性和无症状性患者的其他动脉壁中的 F-NaF 摄取没有差异。
F-NaF PET/MRI 可能是一种有前途的工具,可以更深入地了解斑块易损性。